성인용 백신 시장 보고서(2026년)

Adult vaccines are immunizations administered to induce an immune response against disease-causing pathogens in adults. These vaccines are used for both disease prevention and management. Vaccination helps lessen the severity of illness among individuals at higher risk, such as those with chronic medical conditions or weakened immune systems.

The main types of adult vaccines include monovalent and multivalent vaccines. A monovalent vaccine contains the mRNA component of a single virus and is intended to generate an immune response against one specific antigen. The technologies employed include live attenuated vaccines, inactivated viral or bacterial vaccines, toxoid vaccines, recombinant vaccines, and conjugate vaccines. These vaccines are used across a range of indications, including influenza, dPT, human papillomavirus, zoster, pneumococcal disease, and hepatitis, and are administered by healthcare organizations and hospitals.

Tariffs have impacted the adult vaccines market by increasing import costs of raw materials, biopharmaceutical equipment, and specialized reagents, thereby affecting vaccine production and distribution. Segments like recombinant vaccines and multivalent vaccines are most affected, particularly in regions dependent on imported inputs such as Europe and Asia-Pacific. While tariffs have raised costs and slowed market expansion in some regions, they have also encouraged local manufacturing and investment in domestic production capabilities, creating opportunities for regional vaccine self-sufficiency.

The adult vaccines market research report is one of a series of new reports from The Business Research Company that provides adult vaccines market statistics, including adult vaccines industry global market size, regional shares, competitors with a adult vaccines market share, detailed adult vaccines market segments, market trends and opportunities, and any further data you may need to thrive in the adult vaccines industry. This adult vaccines market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The adult vaccines market size has grown strongly in recent years. It will grow from $24.21 billion in 2025 to $26.34 billion in 2026 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to rising prevalence of infectious diseases, government immunization initiatives, development of novel vaccines, growing geriatric population, increasing healthcare infrastructure.

The adult vaccines market size is expected to see strong growth in the next few years. It will grow to $37.51 billion in 2030 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to advancement in mRNA and recombinant vaccine technologies, increasing investment in adult immunization programs, expansion of cold chain logistics, rising awareness of vaccine-preventable diseases, collaborations between pharma and biotech companies. Major trends in the forecast period include increasing adult vaccination awareness, expansion of immunization programs, development of combination vaccines, growth in chronic disease management vaccines, rising demand for travel and occupational vaccines.

The increase in healthcare expenditure supported the growth of the adult vaccine market. Healthcare expenditure refers to the total spending on healthcare services provided to a population. Increased healthcare spending often leads to greater investment in medical research and development. By directing resources toward vaccination programs and expanding access to vaccines, healthcare systems can reduce the prevalence of preventable diseases and improve overall population health. In addition, adult vaccination can result in significant cost savings by lowering healthcare utilization and minimizing the need for expensive treatments. For instance, in November 2023, according to the Canadian Institute for Health Information, a Canada-based health organization, Canada's total health expenditure in 2023 was projected to reach $344 billion, reflecting an increase of over $9 billion compared to 2022. As a result, the rise in healthcare expenditure positively contributed to the growth of the adult vaccine market.

Major companies are operating in the adult vaccines market and are concentrating on advancing technologies such as mRNA-based vaccines to facilitate rapid and targeted immune response generation in response to the increasing demand for adult immunization against respiratory diseases. An mRNA vaccine employs messenger RNA encapsulated in lipid nanoparticles to instruct human cells to produce specific viral proteins, thereby inducing an immune response without the use of live or attenuated viruses. For instance, in May 2024, Moderna, a US-based biotechnology company, obtained FDA approval for mRESVI, an mRNA-based respiratory syncytial virus (RSV) vaccine for adults aged 60 years and older. The vaccine encodes the prefusion F glycoprotein of RSV and is delivered as a single-dose, pre-filled syringe, promoting neutralizing antibody production, improving safety and efficacy compared to traditional inactivated or live-attenuated vaccines, and expanding adult immunization options.

In December 2023, AstraZeneca, a UK-based developer of respiratory and immune-therapeutic vaccines, acquired Icosavax for up to US$ 1.1 billion. Through this acquisition, AstraZeneca aims to enhance its adult vaccine portfolio by integrating Icosavax's virus-like particle (VLP) vaccine platform and advancing its lead candidate, IVX-A12, a combined RSV and hMPV vaccine intended for older adults. Icosavax, Inc. is a US-based biopharmaceutical company specializing in the development of virus-like particle (VLP) vaccines for respiratory infections in adults.

Major companies operating in the adult vaccines market are GlaxoSmithKline PLC, Merck & Co, Sanofi Pasteur, Pfizer Inc, Commonwealth Serum Laboratories Limited, Johnson & Johnson, Serum Institute of India, AstraZeneca PLC, Novartis AG, Protein Sciences Corporation, Emergent BioSolutions Inc., Bavarian Nordic A/S, Dynavax Technologies Corporation, Novavax Inc, Medimmune LLC, BioNTech SE, Moderna, Inovio Pharmaceuticals, Sinovac, Valneva Se, Biological E Limited, Panacea Biotec, Shenzhen Kangtai Biological Products, Beijing Tiantan Biological Products, Hualan Biological Engineering, Chengdu Institute of Biological Products, Bharat Biotech International Limited, Takeda Pharmaceutical Company Limited

North America was the largest region in the adult vaccines market in 2025. Asia-Pacific is expected to be the fastest-growing region in the adult vaccines market during the forecast period. The regions covered in the adult vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the adult vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The adult vaccines market consists of sales of mRNA vaccines and viral vector vaccines. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Adult Vaccines Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses adult vaccines market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for adult vaccines ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The adult vaccines market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Vaccine Type: Monovalent; Multivalent
• 2) By Technology: Live Attenuated Vaccines; Inactivated Viral Or Bacterial Vaccines; Toxoid Vaccines; Recombinant Vaccines; Conjugate Vaccines
• 3) By Application: Influenza; DPT; Human Papillomavirus; Zoster; Pneumococcal; Hepatitis
• 4) By End Users: Healthcare Firms; Hospitals
• Subsegments:
• 1) By Monovalent: Single Antigen Vaccines; Specific Disease Vaccines
• 2) By Multivalent: Combination Vaccines; Multi-Antigen Vaccines
• Companies Mentioned: GlaxoSmithKline PLC; Merck & Co; Sanofi Pasteur; Pfizer Inc; Commonwealth Serum Laboratories Limited; Johnson & Johnson; Serum Institute of India; AstraZeneca PLC; Novartis AG; Protein Sciences Corporation; Emergent BioSolutions Inc.; Bavarian Nordic A/S; Dynavax Technologies Corporation; Novavax Inc; Medimmune LLC; BioNTech SE; Moderna; Inovio Pharmaceuticals; Sinovac; Valneva Se; Biological E Limited; Panacea Biotec; Shenzhen Kangtai Biological Products; Beijing Tiantan Biological Products; Hualan Biological Engineering; Chengdu Institute of Biological Products; Bharat Biotech International Limited; Takeda Pharmaceutical Company Limited
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Adult Vaccines Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Adult Vaccines Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Adult Vaccines Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Adult Vaccines Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.3 Industry 4.0 & Intelligent Manufacturing
  • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.1.5 Artificial Intelligence & Autonomous Intelligence
• 4.2. Major Trends
  • 4.2.1 Increasing Adult Vaccination Awareness
  • 4.2.2 Expansion Of Immunization Programs
  • 4.2.3 Development Of Combination Vaccines
  • 4.2.4 Growth In Chronic Disease Management Vaccines
  • 4.2.5 Rising Demand For Travel And Occupational Vaccines

5. Adult Vaccines Market Analysis Of End Use Industries

• 5.1 Healthcare Firms
• 5.2 Hospitals
• 5.3 Clinics
• 5.4 Pharmacies
• 5.5 Government Health Agencies

6. Adult Vaccines Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Adult Vaccines Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Adult Vaccines PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Adult Vaccines Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Adult Vaccines Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Adult Vaccines Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Adult Vaccines Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Adult Vaccines Market Segmentation

• 9.1. Global Adult Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Monovalent, Multivalent
• 9.2. Global Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Live Attenuated Vaccines, Inactivated Viral Or Bacterial Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines
• 9.3. Global Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Influenza, DPT, Human Papillomavirus, Zoster, Pneumococcal, Hepatitis
• 9.4. Global Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Healthcare Firms, Hospitals
• 9.5. Global Adult Vaccines Market, Sub-Segmentation Of Monovalent, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Single Antigen Vaccines, Specific Disease Vaccines
• 9.6. Global Adult Vaccines Market, Sub-Segmentation Of Multivalent, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Combination Vaccines, Multi-Antigen Vaccines

10. Adult Vaccines Market Regional And Country Analysis

• 10.1. Global Adult Vaccines Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Adult Vaccines Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Adult Vaccines Market

• 11.1. Asia-Pacific Adult Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Adult Vaccines Market, Segmentation By Vaccine Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Adult Vaccines Market

• 12.1. China Adult Vaccines Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Adult Vaccines Market, Segmentation By Vaccine Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Adult Vaccines Market

• 13.1. India Adult Vaccines Market, Segmentation By Vaccine Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Adult Vaccines Market

• 14.1. Japan Adult Vaccines Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Adult Vaccines Market, Segmentation By Vaccine Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Adult Vaccines Market

• 15.1. Australia Adult Vaccines Market, Segmentation By Vaccine Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Adult Vaccines Market

• 16.1. Indonesia Adult Vaccines Market, Segmentation By Vaccine Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Adult Vaccines Market

• 17.1. South Korea Adult Vaccines Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Adult Vaccines Market, Segmentation By Vaccine Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Adult Vaccines Market

• 18.1. Taiwan Adult Vaccines Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Adult Vaccines Market, Segmentation By Vaccine Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Adult Vaccines Market

• 19.1. South East Asia Adult Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Adult Vaccines Market, Segmentation By Vaccine Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Adult Vaccines Market

• 20.1. Western Europe Adult Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Adult Vaccines Market, Segmentation By Vaccine Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Adult Vaccines Market

• 21.1. UK Adult Vaccines Market, Segmentation By Vaccine Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Adult Vaccines Market

• 22.1. Germany Adult Vaccines Market, Segmentation By Vaccine Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Adult Vaccines Market

• 23.1. France Adult Vaccines Market, Segmentation By Vaccine Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Adult Vaccines Market

• 24.1. Italy Adult Vaccines Market, Segmentation By Vaccine Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Adult Vaccines Market

• 25.1. Spain Adult Vaccines Market, Segmentation By Vaccine Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Adult Vaccines Market

• 26.1. Eastern Europe Adult Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Adult Vaccines Market, Segmentation By Vaccine Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Adult Vaccines Market

• 27.1. Russia Adult Vaccines Market, Segmentation By Vaccine Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Adult Vaccines Market

• 28.1. North America Adult Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Adult Vaccines Market, Segmentation By Vaccine Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Adult Vaccines Market

• 29.1. USA Adult Vaccines Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Adult Vaccines Market, Segmentation By Vaccine Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Adult Vaccines Market

• 30.1. Canada Adult Vaccines Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Adult Vaccines Market, Segmentation By Vaccine Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Adult Vaccines Market

• 31.1. South America Adult Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Adult Vaccines Market, Segmentation By Vaccine Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Adult Vaccines Market

• 32.1. Brazil Adult Vaccines Market, Segmentation By Vaccine Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Adult Vaccines Market

• 33.1. Middle East Adult Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Adult Vaccines Market, Segmentation By Vaccine Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Adult Vaccines Market

• 34.1. Africa Adult Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Adult Vaccines Market, Segmentation By Vaccine Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Adult Vaccines Market Regulatory and Investment Landscape

36. Adult Vaccines Market Competitive Landscape And Company Profiles

• 36.1. Adult Vaccines Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Adult Vaccines Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Adult Vaccines Market Company Profiles
  • 36.3.1. GlaxoSmithKline PLC Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Merck & Co Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Sanofi Pasteur Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Pfizer Inc Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Commonwealth Serum Laboratories Limited Overview, Products and Services, Strategy and Financial Analysis

37. Adult Vaccines Market Other Major And Innovative Companies

• Johnson & Johnson, Serum Institute of India, AstraZeneca PLC, Novartis AG, Protein Sciences Corporation, Emergent BioSolutions Inc., Bavarian Nordic A/S, Dynavax Technologies Corporation, Novavax Inc, Medimmune LLC, BioNTech SE, Moderna, Inovio Pharmaceuticals, Sinovac, Valneva Se

38. Global Adult Vaccines Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Adult Vaccines Market

40. Adult Vaccines Market High Potential Countries, Segments and Strategies

• 40.1 Adult Vaccines Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Adult Vaccines Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Adult Vaccines Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer